Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells

Nucleic Acids Research

Volumn 32, Issue 8, 2004, Pages 2660-2674

  Bordonaro, Michael ^a   Lazarova, Darina L ^a   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; LITHIUM CHLORIDE; LUCIFERASE; WNT PROTEIN; BUTYRIC ACID DERIVATIVE; CRE RECOMBINASE; DIPHTHERIA TOXIN; DIPHTHERIA TOXIN FRAGMENT A; DNA BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; INTEGRASE; ISOBUTYRIC ACID; LEF1 PROTEIN, HUMAN; LYMPHOID ENHANCER FACTOR 1; ONCOPROTEIN; PEPTIDE FRAGMENT; PHOTOPROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN; ZEBRAFISH PROTEIN;

ARTICLE; CANCER CELL; CELL DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TISSUE SPECIFICITY; UPREGULATION; WILD TYPE; APOPTOSIS; COLORECTAL TUMOR; CYTOMEGALOVIRUS; DOWN REGULATION; GENE VECTOR; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BUTYRIC ACIDS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOMEGALOVIRUS; DIPHTHERIA TOXIN; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HERPES SIMPLEX VIRUS PROTEIN VMW65; HUMANS; INTEGRASES; LITHIUM CHLORIDE; LUCIFERASES; LUMINESCENT PROTEINS; LYMPHOID ENHANCER-BINDING FACTOR 1; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; VIRAL PROTEINS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 3042620218     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh596     Document Type: Article

References (49)

1. Su,L.-K., Vogelstein,B. and Kinzler,K. (1993) Association of the APC gene product with β-catenin. Science, 262, 1731-1734.
2. Munimetsu,S., Albert,I., Souza,B., Rubinfeld,B. and Polakis,P. (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl Acad. Sci. USA, 92, 3046-3050.
3. Molenaar,M., van de Wetering,M., Oosterwegel,M., Peterson-Maduro,J., Godsave,S., Korinek,V., Roose,J., Destree,O. and Clevers,H. (1996) XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell, 86, 391-399.
4. Behrens,J., Von Kries,J.P., Kuhl,M., Bruhn,L., Wedlich,D., Grosschedl,R. and Birchmeier,W. (1996) Functional interaction of β-catenin with the transcriptional factor LEF-1. Nature, 382, 638-642.
5. Korinek,V., Barker,N., Morin,P.J., van Wichen,D., de Weger,R., Kinzler,K.W., Vogelstein,B. and Clevers,H. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC -/- colon carcinoma. Science, 275, 1784-1787.
6. Morin,P.J., Sparks,A.B., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K.W. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275, 1787-1790.
7. Kinzler,K.W. and Vogelstein,B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
8. Roose,J. and Clevers,H. (1999) Tcf transcription factors: molecular switches in carcinogenesis. Biochim. Biophys. Acta, 1424, M23-M27.
9. Miyaki,M., Iijima,T., Kimura,J., Yasuno,M., Mori,T., Hayashi,Y., Koike,M., Shitara,N., Iwama,T. and Kuroki,T. (1999) Frequent mutations of β-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res., 59, 4506-4509.
10. Westphal,E.M. and von Melchner,H. (2002) Gene therapy approaches for the selective killing of cancer cells. Curr. Pharm. Des., 8, 1683-1694.
11. Maxwell,I.H., Maxwell,F. and Glode L.M. (1986) Regulated expression of a diphtheria toxin A-chain transfected into human cells: possible strategy for inducing cancer cell suicide. Cancer Res., 46, 4660-4664.
12. Harrison,G.S., Maxwell,F., Long,C.J., Rosen,C.A., Glode,L.M. and Maxwell I.H. (1991) Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rex proteins in transfected cells. Hum. Gene Ther., 2, 53-60.
13. Maxwell,I.H., Glode,L.M. and Maxwell F. (1991) Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells. Cancer Res., 51, 4299-4304.
14. Robinson,D.F. and Maxwell,I.H. (1995) Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain: a potential binary system for toxin gene therapy. Hum. Gene Ther., 6, 137-143.
15. Lidor,Y.J., Lee,W.E., Nilson,J.H., Maxwell I.H., Su,L.J., Brand,E. and Glode,L.M. (1997) In vitro expression of the diphtheria toxin A-chain gene under the control of human gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines. Am. J. Obstet. Gynecol., 177, 579-585.
16. Cao,G.W., Qi,Z.T., Pan,X., Zhang,X.Q., Miao,X.H., Feng,Y., Lu,X.H., Kuriyama,S. and Du,P. (1998) Gene therapy for human colorectal carcinoma using CEA promoter controlled bacterial ADP-ribosylating toxin genes human CEA:PEA & DTA gene transfer. World J. Gastoenterol., 4, 388-391.
17. Kondo,S., Ishizaka,Y., Okada,T., Kondo,Y., Hitomi,M., Tanaka,Y., Haqqi,T., Barnett,G.H. and Barna,B.P. (1998) FADD gene therapy for malignant gliomas in vitro and in vivo. Hum. Gene Ther., 20, 1599-1608.
18. Chen,R.H. and McCormick,F. (2001) Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. Cancer Res., 61, 4445-4449.
19. Qiao,J., Doubrovin,M., Sauter,B.V., Huang,Y., Guo,Z.S., Balatoni,J., Akhurst,T., Blasberg,R.G., Tjuvajev,J.G., Chen,S.H. and Woo,S.L. (2002) Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther., 9, 168-175.
20. Richards,C.A., Austin,E.A. and Huber,B.E. (1995) Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther., 6, 881-893.
21. Ge,K., Jiang,Q., Xu,D.H., Zheng,Z.C. and Liu,X.Y. (1998) Experimental treatment for human colorectal carcinoma by tissue type specific expression of herpes simplex virus thymidine kinase gene. Shi Yan Sheng Wu Xue Bao, 31, 259-264.
22. Kwong,K.Y., Zou,Y., Day,C.-P. and Hung,M.C. (2002) The suppression of colon cancer cell growth in nude mice by targeting β-catenin/TCF pathway. Oncogene, 21, 8340-8346.
23. Nyati,M.K., Sreekumar,A., Li,S., Zhang,M., Rynkiwicz,S.D., Chinnaiyan,A.M., Rehemtulla,A. and Lawrence,T.S. (2002) High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res., 62, 2337-2342.
24. Fuerer,C. and Iggo R. (2002) Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signaling pathway. Gene Ther., 9, 270-281.
25. Malerba,M., Daeffler,L., Rommelaere,J. and Iggo,R.D. (2002) Replicating parvoviruses that target colon cancer cells. J. Virol., 77, 6638-6691.
26. Morita,A., Tsao,D. and Kim,Y.S. (1982) Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line. Cancer Res., 42, 4540-4545.
27. Hague,A., Manning,A.M., Hanlon,K.A., Huschtscha,L.I., Hart,D. and Paraskeva,C. (1903) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55, 498-505.
28. Heerdt,B.G., Houston. M.A. and Augenlicht,L.H. (1994) Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res., 58, 3288-3294.
29. Bordonaro,M., Mariadason,J.M., Aslam,F., Heerdt,B.G. and Augenlicht,L.H. (1999) Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ., 10, 713-720.
30. Bordonaro,M., Lazarova,D.L., Augenlicht,L.H. and Sartorelli,A.C. (2002) Cell type- and promoter-dependent modulation of Wnt signaling pathway by sodium butyrate. Int. J. Cancer, 97, 42-51.
31. Hedgepeth,C.M., Conrad,L.J., Zhang,J. Huang,H.C., Lee,V.M. and Kelin,P.S. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol., 85, 82-91.
32. Staal,F.J., Noort Mv M., Strous,G.J. and Clevers,H.C. (2002) Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep., 3, 65-68.
33. Crawford,H.C., Fingleton,B.M., Rudolph-Owen,L.A., Goss,K.J., Rubinfeld,B., Polakis,P. and Matrisian,L.M. (1999) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene, 18, 2883-2891.
34. Stewart,D.B. and Nelson,W.J. (1997) Identification of four distinct pools of catenins in mammalian cells and transformation-dependent changes in catenin distributions among these pools. J. Biol. Chem., 272, 29652-29662.
35. Lazarova,D.L., Bordonaro,M., Carbone,R. and Sartorelli,A.C. (2004) Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int. J. Cancer, in press.
36. Vecsey-Semjen,B., Becker,K.-F., Sinski,A., Blennow,E., Vietor,I., Zatloukal,K., Beug,H., Wagner,E. and Huber,L.A. (2002) Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Oncogene, 21, 4646-4662.
37. Chinnaiyan,A.M., O'Rourke,K., Tewari,M. and Dixit,V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
38. Kijima,T., Osaki,T., Nishino,K., Kumagai,T., Funakoshi,T., Goto,H., Tachibana,I., Tanio,Y. and Kishimoto,T. (1999) Application of Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Cancer Res., 59, 4906-4911.
39. Ueda,K., Iwahashi,M., Nakamori,M., Nakamura,M., Yamaue,H. and Tanimura,H. (2000) Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma. Oncology, 59, 255-265.
40. Goto,H., Osaki,T., Kijima,T., Nishino,K., Kumagai,T., Funakoshi, T,. Kimura,H., Takeda,Y., Yoneda,T., Tachinana,I. and Hauashi,S. (2001) Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells. Int. J. Cancer., 94, 414-419.
41. Kaczmarczyk,S.J. and Green,J.E. (2001) A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression. Nucleic Acids Res., 29, e56.
42. Ueda,K., Iwahashi,M., Nakamori,M., Nakamura,M., Yamaue,H. and Tanimura H. (2001) Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre-loxP system in the orthotopic gastric carcinoma model. Cancer Res., 61, 6158-6162.
43. Aoki,M., Hecht,A., Kruse,U., Kemler,R. and Vogt,P.K. (1999) Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc. Natl Acad. Sci. USA, 96, 139-144.
44. Cummings,J.H., Pomare,E.W., Branch,W.J., Naylor,C.P. and Macfarlane,G.T. (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 28, 1221-1227.
45. da Costa,L.T., He,T.C., Yu,J., Sparks,A.B., Morin,P.J., Polyak,K., Laken,S., Vogelstein,B. and Kinzler K.W. (1999) CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene, 18, 5010-5014.
46. Tetsu,O. and McCormick,F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
47. Schroder,C., Eckert,K. and Maurer,H.R. (1998) Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. Int. J. Oncol., 13, 1335-1340.
48. Chen,S., Guttridge,D.C., You,Z., Zhang,Z., Fribley,A., Mayo,M.W., Kitajewski,J. and Wang,C.Y. (2001) Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J. Cell Biol., 152, 87-96.
49. Ueda,K., Iwabashi,M., Nakamori,M., Nakamura,M., Matsuura,I., Ojima,T. and Yamaue,H. (2003) Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer. Surgery, 133, 309-317.